FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.

Orca Bio, a commercial-stage biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced the U.S. Food and Drug Administration (FDA) has ...

The Maricopa County Special Health Care District Board of Directors is pleased to announce that it will appoint Michael D. White, MD, MBA, as Valleywise Health's next President and Chief Executive ...

Elson Nash, an education and social impact leader, Senior Fellow at Blue Meridian Partners, and By All Means Senior Fellow at ...

A vast stretch of islands across the South Pacific holds one of the oldest human stories on Earth. For tens of thousands of ...

Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...

Scientists at the University of Minnesota say they've made the first synthetic cell that can complete a life cycle, a major ...

Scientists say they have built a cell from scratch for the first time that can feed, grow and replicate like a natural cell. This breakthrough in synthetic biology could usher in an era of ...

Following the week at the Miss Oregon Scholarship Program’s pageant in Seaside, Miss Umpqua Valley’s Teen Addison Reneau said ...

Female mammals have long thought to be born with all the eggs they would ever have, but new research is challenging that consensus ...

From a bird prepared by a president to a monumental cave carved by water over millions of years, “From These Lands” reveals ...